Tag: nasdaq:biib

May 28, 2019

8 Small Biotech ETFs

Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
January 4, 2019

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers

Biogen (Nasdaq:BIIB) and Skyhawk Therapeutics announced a strategic collaboration in which the companies will leverage Skyhawk’s SkySTAR™ technology platform with the...
November 1, 2018

VIDEO — Life Science Update October 2018

With October behind us, the Investing News Network (INN) has brought together some of the biggest stories in the life...
October 24, 2018

Forward Pharma Loses Patent Appeal Trial

The appeal was against Biogen’s drug Tecfidera. Forward will lose out on future royalty payments for Biogen’s commercial product in...
October 18, 2018

Abbvie’s Humira Faces Biosimilar Competition

The long wait for Biogen’s European launch of Imraldi was due to its legal battle with Abbvie over Humira.
July 6, 2018

Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months

Eisai and Biogen (NASDAQ:BIIB) announced positive topline results from the Phase II study with BAN2401, an anti-amyloid beta protofibril antibody,...